New research from Queen Mary University of London, published in Nature Medicine, has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat ...
May 19, 2022
0
27
Researchers from the University of Adelaide and the Radboud University Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood ...
May 12, 2022
0
18
Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease.
Apr 7, 2022
0
507
Despite guidelines that call for early and aggressive treatment of rheumatoid arthritis, a new study suggests many older adults are not prescribed disease-modifying medications for their inflammatory autoimmune disease.
Apr 7, 2022
0
11
Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and ...
Mar 23, 2022
0
70
(HealthDay)—Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson's disease, new research shows.
Jan 28, 2022
0
26
(HealthDay)—Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.
Jan 27, 2022
0
14
New research led by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) scientists has profiled the side effects of methotrexate—a common drug used to treat arthritis and other autoimmune diseases.
Jan 26, 2022
0
5
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids, ...
Jan 13, 2022
0
108
